The business of general practice, daily

PH Medical Centres Pty Ltd, part of the Quadrant-backed Partnered Health Group, notified the ACCC on 3 July 2026 of its proposed acquisition of Ryan Plaza Medical Services Pty Ltd, which operates a single primary care centre, 'Medicine on Second', at Maroochydore with 11 GPs. Notification MN-15027. The ACCC has issued a questionnaire and submissions close 10 July 2026. The register filing describes the PH Primary Care Group as 67 general practice clinics and about 570 GPs, plus skin cancer clinics, allied health and the TeleWell telehealth platform.

This is the first GP practice acquisition to appear on the public register since mandatory merger notification commenced on 1 January 2026, and it answers a question the regime had left open: does the $50m three-year cumulative threshold, which aggregates individually small purchases by serial acquirers, reach a single suburban clinic? It does. An 11-GP practice on its own is nowhere near the headline thresholds; Partnered Health's accumulated buying gets it there. Every bolt-on by a corporate, PE platform or insurer above that cumulative line now carries a filing, a public consultation window and typically 15 to 20 business days of clearance time. Sub-threshold independent buyers carry none of that.

The second read: Partnered Health is still buying while Bupa's acquisition of the whole group, announced 18 June, awaits ACCC and FIRB approval. The platform keeps growing while the sale is pending, and whoever ends up owning the group, the Sunshine Coast clinic comes with it.

AFR Street Talk's 18 June report on the Bupa-Partnered Health deal carried a $450m value. Street Talk's first report two days earlier, on 16 June, said '$400m-plus', so AFR's own number firmed by around $50m between the two pieces. Bupa's announcement did not disclose consideration, and no other named outlet has printed a figure. Whether $450m is equity or enterprise value, and whether any earn-out sits behind it, is not public.

Taken at face value, at roughly 71 clinics (Bupa's announcement said 68 primary care plus three urgent care; the ACCC register filing above says 67 primary care) plus the corporate health and wellbeing brands, $450m implies in the order of $6m per clinic across the group. The 16 June piece also carried a Partnered Health earnings forecast of $40m-plus EBITDA, which puts $450m at about 11 times forward earnings. That arithmetic is ours and indicative only, and the corporate health division carries part of the value. It is still the first public reference point for how an insurer prices network-scale primary care against single-practice multiples.

The ACCC notification for Allianz Partners' acquisition of nib's Australian and New Zealand travel insurance portfolio (MN-80024) was filed on 3 July, the same day as Ryan Plaza. nib announced the sale on 4 June: up to $50m, roughly $30m payable on completion and $20m conditional on performance over the first 12 months, plus a 20-year distribution agreement under which Allianz keeps issuing nib-branded travel cover (the term is in Allianz's announcement; nib's own release says only 'long-term').

Not a GP transaction, but it belongs in the insurer-capacity picture. nib exits a non-core line while keeping its health core, including the Hub.health and Midnight Health digital GP channel. That makes three private health insurers reallocating capital toward core health in 2026: Medibank consolidating Better Medical into Amplar, Bupa buying Partnered Health, and nib shedding travel.